Back to resultsAlzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Primary Purpose
Alzheimer's Disease
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
estrogen
Sponsored by
About this trial
This is an interventional treatment trial for Alzheimer's Disease
Eligibility Criteria
Post menopausal women with alzheimer's disease free of any major medical or neurological disease, medically safe to be treated with estrogen.
Sites / Locations
- VA Puget Sound Health Care System
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00018343
First Posted
July 3, 2001
Last Updated
January 20, 2009
Sponsor
US Department of Veterans Affairs
1. Study Identification
Unique Protocol Identification Number
NCT00018343
Brief Title
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Official Title
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Study Type
Interventional
2. Study Status
Record Verification Date
December 2004
Overall Recruitment Status
Completed
Study Start Date
April 1998 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
March 2001 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
US Department of Veterans Affairs
4. Oversight
5. Study Description
Brief Summary
This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer's Disease
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
estrogen
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
90 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Post menopausal women with alzheimer's disease
free of any major medical or neurological disease,
medically safe to be treated with estrogen.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Suzanne Craft, Ph.D
First Name & Middle Initial & Last Name & Degree
Laura Baker, Ph.D
First Name & Middle Initial & Last Name & Degree
Murray Raskind, M.D.
Facility Information:
Facility Name
VA Puget Sound Health Care System
City
Lakewood
State/Province
Washington
ZIP/Postal Code
98493-5000
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
We'll reach out to this number within 24 hrs